drugset / Trial / NCT01931007

Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis

NCT01931007 ↗

Phase 1 Completed 25 enrolled Mayo Clinic
RandomizedSingle-groupSingle-blindTreatment

Summary

The overall goal of this study is to develop regenerative cell therapy for use in patients with osteoarthritis (OA). The primary objective of this proposal is to conduct a pilot study that assesses the safety and feasibility of using concentrated bone marrow aspirate containing MSC to treat patients with painful knee OA.

Timeline

Start
2013-08
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Bone Marrow Aspirate Concentrate Unknown 5 ml Other

Indications